Hepatic MR imaging with ferumoxides: Multicenter study of safety and effectiveness of direct injection protocol

被引:29
作者
Bluemke, DA
Weber, TM
Rubin, D
de Lange, EE
Semelka, R
Redvanly, RD
Chezmar, J
Outwater, E
Carlos, R
Saini, S
Holland, GA
Mammone, JF
Brown, JJ
Milestone, B
Javitt, MC
Jacobs, P
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Good Samaritan Hosp, San Jose, CA USA
[4] Univ Virginia, Charlottesville, VA USA
[5] Scatliff MRI, UNC Hosp, Chapel Hill, NC USA
[6] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[7] Emory Univ Hosp, Atlanta, GA 30322 USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
[10] Med Coll Penn Tenet, Philadelphia, PA USA
[11] Univ Camden, Cooper Hosp, Med Ctr, Camden, NJ USA
[12] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
[13] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[14] George Washington Univ, Ctr Med, Washington, DC USA
[15] Adv Magnet, Cambridge, MA USA
关键词
contrast media; iron; liver neoplasms; diagnosis; MR;
D O I
10.1148/radiol.2282012061
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To compare the Safety and effectiveness of an undiluted direct injection of fetumoxides with those of a diluted slow infusion of ferumoxides during 30 minutes in patients with known liver lesions or in those suspected of having them. MATERIALS AND METHODS: Two hundred thirty-three patients at 16 institutions were randomized to receive either an undiluted direct injection of 0.56 mg of iron per kilogram of body weight of ferumoxides administered during 2 minutes (2 mL/min) or a diluted slow infusion administered during 30 minutes. Safety was assessed with monitoring for adverse events and laboratory tests. For sensitivity, specificity, and accuracy analysis, two independent blinded observers identified and classified lesions as benign or malignant with precontrast images and with pre- and postcontrast images combined., RESULTS: There was no statistically significant difference in adverse events in the, group with direct injection compared with those in the group with infusion (21 [18%] of 114 patients vs 19 [17%] of 112 patients, respectively). No serious adverse events were observed. The most common adverse events in the group with direct injection versus the group with infusion were headache (five [4%] of 114 vs three [3%] of 112, respectively) and back, pain (five [4%] of 114 vs three [3%] of 112, respectively). Overall, in 68 (62%) of 109 patients with direct injection and 71 (66%) of 108 patients with infusion, additional magnetic resonance (MR) imaging information was obtained after, ferumoxides administration (P = .67). Sensitivity, i specificity, and accuracy for the diagnosis of malignancy were significantly improved by adding images obtained after ferumoxides administration to the images obtained before contrast agent administration (P < .05 for all comparisons). CONCLUSION: Direct injection of ferumoxides has safety and effectiveness profiles similar to those of slow infusion of the agent. Further findings indicate that the addition of ferumoxides increases-the sensitivity and specificity of hepatic MR evaluation when compared with unenhanced MR imaging. (C) RSNA, 2003.
引用
收藏
页码:457 / 464
页数:8
相关论文
共 18 条
[1]   Detection of hepatic lesions in candidates for surgery: Comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT [J].
Bluemke, DA ;
Paulson, EK ;
Choti, MA ;
DeSena, S ;
Clavien, PA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (06) :1653-1658
[2]   MR imaging of intrahepatic cholangiocarcinoma: Use of ferumoxides for lesion localization and extension [J].
Braga, HJV ;
Imam, K ;
Bluemke, DA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 177 (01) :111-114
[3]   Preoperative detection of hepatocellular carcinoma: Ferumoxides-enhanced MRI imaging versus combined helical CT during arterial portography and CT hepatic arteriography [J].
Choi, D ;
Kim, SH ;
Lim, JH ;
Lee, WJ ;
Jang, HJ ;
Lee, SJ ;
Lim, HK .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (02) :475-482
[4]   DETECTION OF LIVER METASTASES - COMPARISON OF SUPERPARAMAGNETIC IRON OXIDE-ENHANCED AND UNENHANCED MR-IMAGING ART 1.5 T WITH DYNAMIC CT, INTRAOPERATIVE US, AND PERCUTANEOUS US [J].
HAGSPIEL, KD ;
NEIDL, KFW ;
EICHENBERGER, AC ;
WEDER, W ;
MARINCEK, B .
RADIOLOGY, 1995, 196 (02) :471-478
[5]  
Imam K, 2000, Magn Reson Imaging Clin N Am, V8, P741
[6]   Preoperative detection of malignant hepatic tumors: Comparison of combined methods of MR imaging with combined methods of CT [J].
Kondo, H ;
Kanematsu, M ;
Hoshi, H ;
Murakami, T ;
Kim, T ;
Hori, M ;
Matsuo, M ;
Nakamura, H .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (04) :947-954
[7]  
Müller RD, 1999, ACTA RADIOL, V40, P628
[8]   Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging [J].
Oudkerk, M ;
vandenHeuvel, AG ;
Wielopolski, PA ;
Schmitz, PIM ;
Rinkes, IHMB ;
Wiggers, T .
RADIOLOGY, 1997, 203 (02) :449-456
[9]   Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging [J].
Paley, MR ;
Mergo, PJ ;
Torres, GM ;
Ros, PR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (01) :159-163
[10]   Hepatic MR imaging using ferumoxides: Prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases [J].
Raman, SS ;
Lu, DSK ;
Chen, SC ;
Sayre, J ;
Eilber, F ;
Economou, J .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 177 (04) :807-812